Source BioScience UK has acquired clinical healthcare testing service provider Cambridge Clinical Laboratories (CCL), enhancing its clinical diagnostics portfolio. The acquisition enables Source ...

Adjusted* EBITDA increased by 13% to £5.8 million (2014: £5.1 million) Adjusted* profit before tax increased by 15% to £3.3 million (2014: £2.8 million) Profit before tax up 40% to £2.0 million (2014: ...

Source BioScience’s GenomeCube includes 20 million clones and antibodies. Source BioScience and DNAFORM are launching the Japanese version of Source BioScience’s GenomeCube® database and webstore.

Source BioScience UK Ltd, announced it had completed the acquisition of Cambridge Clinical Laboratories (CCL). The acquisition bolsters the Company’s clinical diagnostics portfolio by leveraging the ...

With this acquisition, Source BioScience is now able to offer integrated solutions to customers, with environmentally controlled storage in combination with the required up- or downstream analytical ...

The £63m sale of Nottingham-based laboratory services provider Source BioScience has moved closer. On Friday, the firm's shareholders voted in favour of the sale to Sherwood Holdings, which was ...

Source BioScience has expanded its market leading DNA sequencing service in Ireland with the official opening of its new laboratory in Tramore, County Waterford. The opening was conducted by John ...

19 January 2012 NOTTINGHAM, England -(BUSINESS WIRE/ME NewsWire)-- Source BioScience plc (LSE: SBS) ("Source BioScience" or the "Company"), the international diagnostic and genetic analysis business, ...

Source BioScience Limited is an international provider of integrated state of the art Laboratory Services and Products. Headquartered in the UK, with offices in UK, Europe and the USA, Source ...

Source Bioscience, the Nottingham-based laboratory services provider, is to be sold in a deal worth £63m. The company will be bought by Sherwood Holdings, which was recently established by Continental ...

Source BioScience UK Ltd, an industry-leading provider of genomic services and histopathology diagnostics, today announced it had completed the acquisition of Cambridge Clinical Laboratories (CCL), a ...